Xenon Pharmaceuticals Inc. (XENE)

Bally's Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	116.66	142.71	148.64	57.24	175.69	45.01
Short-Term Investments	432.97	484.19	489.44	534.85	376.09	131.99
Cash & Short-Term Investments	549.63	626.91	638.08	592.09	551.77	177
Cash Growth	-21.44%	-1.75%	7.77%	7.31%	211.74%	25.21%
Accounts Receivable	8.65	1.47	0.87	0.99	2.77	1.82
Receivables	8.65	1.47	0.87	0.99	2.77	1.82
Prepaid Expenses	7.26	6.89	6.01	7.23	4.48	2.96
Total Current Assets	565.54	635.26	644.96	600.3	559.02	181.78
Property, Plant & Equipment	17.31	18.22	18.85	16.91	12.52	6.88
Long-Term Investments	141.5	127.5	292.79	128.68	-	-
Long-Term Deferred Tax Assets	10.88	9.67	0.8	0.51	0.47	0.52
Other Long-Term Assets	8.05	7.5	7.4	7.75	-	-
Total Assets	743.28	798.14	964.8	754.15	572.01	189.19
Accounts Payable	6.88	5.07	8.6	8.49	3.82	3.04
Accrued Expenses	16.76	22.75	17.03	13.38	9.78	7.76
Current Portion of Leases	1.38	1.37	1.3	0.49	0.61	0.27
Current Income Taxes Payable	6.56	5.69	0.35	-	-	-
Current Unearned Revenue	-	-	-	-	-	3.64
Other Current Liabilities	0.45	0.71	-	0.34	0.12	0.07
Total Current Liabilities	32.03	35.59	27.27	22.7	14.32	14.78
Long-Term Leases	7.29	7.65	9.6	9.95	7.65	3.05
Total Liabilities	39.32	43.24	36.88	32.65	21.97	17.83
Common Stock	1,461	1,457	1,436	1,065	790.9	405.48
Additional Paid-In Capital	208.46	199.15	156.76	142.11	117.5	45.36
Retained Earnings	-964.52	-899.47	-665.14	-482.75	-357.37	-278.49
Comprehensive Income & Other	-0.84	-1.61	-0.08	-3	-0.99	-0.99
Shareholders' Equity	703.96	754.9	927.92	721.5	550.03	171.36
Total Liabilities & Equity	743.28	798.14	964.8	754.15	572.01	189.19
Total Debt	8.68	9.02	10.9	10.44	8.26	3.32
Net Cash (Debt)	682.45	745.39	919.97	710.33	543.52	173.68
Net Cash Growth	-22.01%	-18.98%	29.51%	30.69%	212.94%	39.05%
Net Cash Per Share	8.73	9.57	13.75	11.73	12.46	4.82
Filing Date Shares Outstanding	76.73	76.54	75.43	63.04	52.94	36.83
Total Common Shares Outstanding	76.59	76.42	75.37	62.59	52.65	36.03
Working Capital	533.51	599.67	617.69	577.6	544.7	167
Book Value Per Share	9.19	9.88	12.31	11.53	10.45	4.76
Tangible Book Value	703.96	754.9	927.92	721.5	550.03	171.36
Tangible Book Value Per Share	9.19	9.88	12.31	11.53	10.45	4.76
Machinery	-	14.38	11.89	11	10.8	12.32
Leasehold Improvements	-	9.36	9.02	4.2	7.02	6.39

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q